Month: September 2025

MONTREAL, Sept. 11, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a Quebec-based technology company driving innovation in advanced materials and critical process development, is pleased to announce it has been awarded up to $3 million in funding by the Government of Canada. This investment comes from the Energy Innovation Program’s Battery Industry Acceleration call for proposal, administered by Natural Resources Canada. The funding will help cover the capital costs and accelerate the building HPQ’s first 50-tonne-per-year continuous production system to manufacture silicon-based material for lithium-ion batteries. Developed in collaboration with technology partner Novacium [1], this material is at the core of HPQ ENDURA+ commercial 18650 (4,000 mAh) and 21700 (6,000 mAh)...

Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for both intended indications of PKU and CKD Dose-dependent urinary amino acid excretion demonstrated across all SAD and MAD cohorts, including up to a 42-fold increase in urinary phenylalanine (Phe) excretion, a well-validated biomarker for PKU and predictive for CKD Dose-dependent initial eGFR dip similar to SGLT2 inhibitors observed, supporting a potential kidney protective effect in CKD Well tolerated across all doses with an excellent safety profile and no serious adverse events observed Phase 2 trials in both PKU and CKD expected to initiate in 2026 Maze to host investor conference call and webcast today at 8:30 am EDT SOUTH SAN FRANCISCO, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc....

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long acting, scalable, and combinable therapies at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) held September 15-19, 2025, in Vienna, Austria. “As we progress our pipeline of ultra-long acting next-generation nutrient-stimulated hormone, or NuSH, therapies, we are encouraged by the opportunity to leverage our investigational medicines both as monotherapies and in combination with each other,” said Steve Marso, M.D., Chief Medical Officer at Metsera. “Our late-breaker highlights the initial clinical results...

TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE; FSE: PNX) (“Pasinex” or the “Company”) today announced it has executed a Share Transfer and Settlement Agreement (the “Agreement”) with Kurmel Holding A.S., Akmetal Dis Ticaret Madencilik Sanayi ve Ticaret A.Ş. Akmetal Madencilik Sanayi ve Ticaret A.Ş. and Birant Kurmel (all together “Kurmel Holding”), Pasinex Arama ve Madencilik A.Ş. (“Pasinex Arama”) and Horzum Maden Arama ve İşletme A.Ş. (“Horzum A.Ş.”). Under the Agreement, Kurmel Holding will transfer its 50% shareholding in Horzum A.Ş. to Pasinex Arama. Completion of the share transfer is subject to approval by Türkiye’s General Directorate of Mining and Petroleum Affairs (“MAPEG”) and other customary corporate and registration steps. Upon receipt of approvals and completion of registrations,...

Sanoma Corporation, Press Release, 11 September 2025 at 14:00 EET Sanoma plans to centralise its printing operations to the Helsinki area and close its printing facility in Tampere Sanoma Media Finland is planning to centralise its news media printing operations to the Helsinki metropolitan area in Sanomala, Finland’s largest printing house, and to close the Sanoma Manu printing facility in Tampere. The plan is based on the accelerating shift of media consumption towards digital channels. As a result of smaller print runs of newspapers, the unit costs of printing have increased. In the future, the newspapers produced by Sanoma could be printed more cost-efficiently in a single printing facility without a significant impact on customers. Decisions on final plans will be made after a change negotiation process has been concluded in line...

New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses Results Provide Further Validation of the Systemic Component of a Dual-Route Administration Strategy Enabeling Potential Targeting of Both Primary Tumors and Metastatic Disease  Silexion Remains on Track for Phase 2/3 Trial Initiation in H1 2026 Following Planned Q4 2025 and Q1 2026 Regulatory Submissions GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced new preclinical data demonstrating that subcutaneously administered SIL204 successfully reaches all primary sites of pancreatic cancer...

Miami, FL, Sept. 11, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared a quarterly dividend of $0.15 per share, or $0.60 per share on an annualized basis, for the third quarter of 2025. Shareholders of record as of the close of business on September 30, 2025 will be paid a dividend of $0.15 on October 31, 2025. About TecnoglassTecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural...

CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions, today announced key leadership updates. Stacie Schulz has been appointed Chief Accounting Officer, reporting to Chief Financial Officer Laura Kowalchik. Stacie brings extensive experience in technical accounting, SEC reporting, and financial operations, having held senior leadership roles at Superior Industries, Tenneco, and Federal-Mogul Holdings Corporation. Randy Wilson, who has recently joined Methode as Vice President of Global Treasury, has assumed responsibility for Investor Relations, bringing together both functions under the title of Vice President, Global Treasury & Investor Relations. Randy brings 20 years of expertise in corporate treasury, investor relations, and financial...

Technologies will optimize offshore production in the Sakarya Gas Field Baker Hughes to deliver deepwater horizontal tree systems with associated technology Integrated approach will enhance operating efficienciesHOUSTON and LONDON, Sept. 11, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Thursday a significant award from Turkish Petroleum (TPAO) and Turkish Petroleum Offshore Technology Center (TP-OTC) to supply subsea production and intelligent completion systems in the country’s strategic Sakarya Gas Field Phase 3. Through the agreement, Baker Hughes will provide deepwater horizontal tree systems with associated subsea structures and control systems to support production at depths from 6,500 to 7,200 feet. The company’s advanced, intelligent upper and lower completions systems will...

The state-of-the-art Norton facility intended to align with Department of Defense and Department of Homeland Security production requirements, supporting a roadmap for federal expansion and strategic access to Washington, D.C. MIAMI, Sept. 11, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company” or “Wrap”), a global leader in pre-escalation and public safety solutions, today announced the official opening of its new U.S. Manufacturing World Headquarters in Norton, Virginia, located in Wise County in the heart of Southwest Virginia.The new facility expands Wrap’s Made-In-America production footprint. Built to manufacture up to 23,000 BolaWrap® 150 devices and more than 150,000 cassettes per month, with future expansion capacity expected to double or triple output as demand grows. In addition, the site...